Table 1.
Study Baseline Demographic and Clinical Characteristics in Relation to the Presence or Absence of ECG LVH by Both CP and SL at Baseline
| Variables | CP−/SL− (n=2023) | CP+/SL− (n=5220) | CP−/SL+ (n=990) | CP+/SL+ (n=960) | P Value |
|---|---|---|---|---|---|
| Age, y | 66.1±7.1 | 67.2±7.0 | 66.5±7.0 | 67.7±6.8 | <0.001 |
| Female sex, % | 56.7 | 58.4 | 32.5 | 46.0 | <0.001 |
| Black race, % | 5.3 | 4.0 | 13.6 | 8.5 | <0.001 |
| Diabetes mellitus, % | 11.6 | 14.5 | 10.1 | 10.4 | <0.001 |
| History of ischemic heart disease, % | 13.0 | 16.4 | 18.0 | 17.9 | <0.001 |
| History of myocardial infarction, % | 5.2 | 6.6 | 6.3 | 6.1 | 0.214 |
| History of arrhythmia, % | 5.2 | 7.0 | 8.0 | 9.8 | <0.001 |
| History of stroke, % | 3.6 | 4.3 | 5.7 | 5.2 | 0.031 |
| History of heart failure, % | 0.8 | 2.1 | 1.1 | 3.1 | <0.001 |
| History of peripheral vascular disease, % | 5.7 | 5.3 | 5.7 | 7.6 | 0.043 |
| Current smoker, % | 17.4 | 13.8 | 23.1 | 20.7 | <0.001 |
| Prior antihypertensive treatment, % | 71.8 | 73.4 | 67.9 | 70.9 | 0.003 |
| Randomized treatment (% losartan) | 50.5 | 50.0 | 49.2 | 50.8 | 0.870 |
| Body mass index, kg/m2 | 27.9±4.7 | 28.7±4.8 | 25.5±3.8 | 26.8±4.6 | <0.001 |
| Serum glucose, mmol/L | 5.90±2.03 | 6.14±2.31 | 5.80±1.99 | 5.87±2.02 | <0.001 |
| Total cholesterol, mmol/L | 6.03±1.12 | 6.08±1.13 | 5.85±1.08 | 6.05±1.15 | <0.001 |
| HDL cholesterol, mmol/L | 1.50±0.43 | 1.48±0.43 | 1.54±0.45 | 1.51±0.44 | <0.001 |
| Creatinine, μg/mmol/L | 85.4±19.7 | 85.8±19.4 | 92.3±23.0 | 90.7±21.0 | <0.001 |
| UACR, mg/mmol/L | 4.7±16.1 | 8.0±38.8 | 9.7±38.7 | 9.2±28.6 | <0.001 |
CP indicates Cornell product; HDL, high‐density lipoprotein; LVH, left ventricular hypertrophy; SL, Sokolow‐Lyon voltage; UACR, urine albumin/creatinine ratio.